Dermatomyositis in a Patient with Cholangiocarcinoma Detected by an [18F]-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Scan
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cholangiocarcinoma with paraneoplastic dermatomyositis (DM) is extremely rare, and the whole body positron emission tomography–computed tomography (PET-CT) finding of paraneoplastic DM is rarely reported. We report a 66-year-old woman with metastatic cholangiocarcinoma, initially presented with bilateral proximal muscle uptake on PET-CT without clinical muscle symptoms. The initial interpretation of the high muscle uptake was metastasis to the muscles. However, while awaiting for chemotherapy, muscle weakness evolved and rapidly progressed. The level of creatine phosphokinase was significantly elevated. Electromyography revealed moderate myopathy, and a muscle biopsy showed degenerating myofibers with variable sizes. The diagnosis of paraneoplastic dermatomyositis was made. This case highlights that, although rare, paraneoplastic dermatomyositis can be present with cholangiocarcinoma. Also, muscle inflammation can precede the clinical muscle symptoms, and paraneoplastic DM should be considered as a possible differential diagnosis in the assessment of cancer patients who present with abnormal muscle tracer uptake in PET-CT scans.
Abstract
Cholangiocarcinoma with paraneoplastic dermatomyositis (DM) is extremely rare, and the whole body positron emission tomography–computed tomography (PET-CT) finding of paraneoplastic DM is rarely reported. We report a 66-year-old woman with metastatic cholangiocarcinoma, initially presented with bilateral proximal muscle uptake on PET-CT without clinical muscle symptoms. The initial interpretation of the high muscle uptake was metastasis to the muscles. However, while awaiting for chemotherapy, muscle weakness evolved and rapidly progressed. The level of creatine phosphokinase was significantly elevated. Electromyography revealed moderate myopathy, and a muscle biopsy showed degenerating myofibers with variable sizes. The diagnosis of paraneoplastic dermatomyositis was made. This case highlights that, although rare, paraneoplastic dermatomyositis can be present with cholangiocarcinoma. Also, muscle inflammation can precede the clinical muscle symptoms, and paraneoplastic DM should be considered as a possible differential diagnosis in the assessment of cancer patients who present with abnormal muscle tracer uptake in PET-CT scans.
참고문헌 (15)
- Targoff IN, "Dermatoniyositis and polymyositis", Curr Probl Dermatol, 3, pp.134~180 (1991)
- Hill CL, "Frequency of specific cancer types in dermatomyositis and polymyositis : a population-based study", Lancet, 357, pp.96~100 (2001)
- Knowles BP, "Reading the signs : occult metastatic cholangiocarcinoma detected by full-body screening in dermatomyositis", ANZ J Surg, 77, pp.1026~1027 (2007)
- 최성형, "침윤성 간내담도암과 동반된 피부근육염 1예", 대한류마티스학회지, 17(1), pp.76~80 (2010), 대한류마티스학회
- Horie Y, "Combined hepatocellular-cholangiocarcinoma associated with dermatomyositis", J Gastroenterol Hepatol, 4, pp.101~104 (1989)
- Warburg O, "On the origin of cancer cells", Science, 123, pp.309~314 (1956)
- Al-Nahhas A, "PET", CT imaging in inflammatory myopathies, 2011, pp.1228, 39~45
- Mummadi V, "Abnormal 18F-fluorodeoxyglucose(FDG)uptake in muscle tumors on PET-CT : a pictorial atlas of pathologic findings", J Nucl Med, 51(Suppl 2), pp.1090~ (2010)
- Casciola-Rosen L, "Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy", J Exp Med, 201, pp.591~601 (2005)
- Kaji K, "Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis : an association with malignancy", Rheumatology(Oxford), 46, pp.25~28 (2007)
- Yoshinaga A, "Successful cure of dermatomyositis after treatment of nonseminomatous testicular cancer", Int J Urol, 12, pp.593~595 (2005)
- Takahashi F, "Successful resection of dermatomyositis associated with thymic carcinoma : report of a case", Surg Today, 38, pp.245~248 (2008)
- Gunawardena H, "Myositis-specific autoantibodies : their clinical and pathogenic significance in disease expression", Rheumatology(Oxford), 48, pp.607~612 (2009)
- Noss EH, "Rituximab as therapy for refractory polymyositis and dermatomyositis", J Rheumatol, 33, pp.1021~1026 (2006)
- Hengstman GJ, "Anti-signal recognition particle autoantibodies : marker of a necrotising myopathy", Ann Rheum Dis, 65, pp.1635~1638 (2006)